Patients must have serum chemistries (including potassium and magnesium) within  days prior to registration to obtain baseline values
Abnormal serum calcium, magnesium, or potassium levels
Sodium or potassium outside normal reference range for site
The patient has serum electrolytes (including calcium, magnesium, phosphorous, sodium and potassium) within normal limits (supplementation to maintain normal electrolytes is allowed).
The following assessments are required within  days prior to registration: sodium (Na), potassium (K), chloride (Cl), glucose, calcium (Ca), magnesium (Mg), and albumin
Potassium and magnesium within normal range
Patients with uncorrectable electrolyte abnormalities with potassium (K) > ULN (upper limit of normal)
Serum sodium and potassium within the institutional limits of normal, within  days of registration and within  days of the start of treatment
Potassium within normal limits (WNL)
Potassium within institutional normal limits
Patients whose electrolytes (sodium, potassium, calcium, magnesium) are abnormal or cannot be normalized with standard intervention on the day of treatment with study drug
Potassium within institutional normal limit (WNL)
Potassium within normal limits prior to the first dose of study medication
The following laboratory values must be greater than the lower limits of normal prior to starting study drug (supplementation allowed): potassium, magnesium, calcium
Serum sodium, potassium, magnesium and calcium within normal limits for the institution (supplements may be given to correct values)
Clinically significant abnormal serum potassium (regardless of potassium agent supplementation); serum calcium (ionic or binding to albumin post-adjusted) or serum magnesium (regardless of magnesium agent supplementation);
Potassium before the first dose of ceritinib
Potassium within normal limits for the institution
For Phase I and II: Serum potassium, magnesium, and calcium (normalized for albumin) levels should be at least within institutional normal limits.
Clinically significant electrolyte disorders including sodium <  or >  and/or potassium < . or > . and/or magnesium < . or > .
Serum potassium, magnesium, and calcium levels normal per current Yale-New Haven Hospital (YNHH) lab medicine standards (may be corrected to those levels by supplementation during screening period) within  weeks prior to start of any therapy
Potassium, magnesium and phosphorus within the normal range for the institution (supplementation is permissible)
Patients with sodium, potassium, or creatinine serum electrolytes > grade .
Potassium within normal limits for the institution
Serum potassium, magnesium and calcium levels which fall within normal limits or levels outside the normal range determined not to be clinically significant by the principal investigator (PI)
Serum potassium, magnesium, and calcium levels within  days before randomization must be within normal limits (WNL) for the lab within  days before randomization
Potassium within normal limits (oral supplementation is allowed)
Serum potassium within normal limits
Potassium (K) and magnesium (Mg) >= grade  toxicity
Serum potassium >= . mEq/L\r\n* Hypokalemia can be managed and corrected at the physicians discretion; patients who have hypokalemia must have a repeat serum potassium level drawn within  days before starting study drug; patients with a supported potassium level at >= . can be considered eligible at the physicians discretion
Serum potassium levels outside the laboratorys reference range
Patient must have magnesium, calcium, glucose, potassium and sodium levels within normal limits
Serum potassium within institutional limits of normal (may be corrected with potassium repletion)
Sodium (Na), potassium chloride (K Cl), carbon dioxide (CO), calcium (Ca), phosphate (PO) within institutional limits
Potassium within normal limits for the institution
Serum potassium and magnesium-within normal limits (WNL)
Serum potassium, magnesium and calcium within normal limits (supplementation to maintain normal electrolyte levels is acceptable)
Potassium within normal limits for the institution
Patients with abnormal calcium, potassium, or magnesium levels that is or cannot be adequately corrected to =< grade  prior to initiation of study drugs
Potassium within normal limits
Potassium
Potassium levels =< grade 
Calcium (Ca), magnesium (Mg), potassium (K) within normal
Abnormal electrolytes such as potassium, magnesium and calcium, or abnormal organ functions such as decreased creatinine clearance.
Use of potassium wasting diuretics during study treatment
Serum calcium, magnesium, potassium within normal limits, or if outside of normal limits, must be deemed clinically insignificant by the investigator
Serum potassium within normal limits (WNL)
Potassium (K) levels: preferred normal limits with no clinical abnormalities
Potassium levels within normal limits
Serum potassium and magnesium levels within institutional normal limits; patients with low potassium and magnesium levels may be repleted to allow for protocol entry
Serum electrolyte values (sodium, potassium, magnesium, calcium) must be checked prior to enrollment and clinically significant abnormalities corrected prior to surgery/AdV-tk injection
Serum electrolyte values < Grade  (sodium, potassium, calcium, phosphorous and magnesium), per CTCAE v...
Subjects with > Grade  (high or low) serum potassium, magnesium, or calcium levels.
Potassium within normal limits for the institution
Potassium >= . mg/dl and =< upper limit of normal
Serum potassium and magnesium levels within normal limits
Serum potassium, and magnesium within normal limits
Serum potassium > .; electrolyte repletion is allowed to reach these values
Subject has any abnormalities in serum sodium, potassium, chloride, calcium and magnesium levels ? Grade  at screening (CTCAE Version .).
Normal serum potassium magnesium levels
Serum potassium, magnesium, and calcium levels (corrected for albumin) outside the laboratorys reference range despite correction
Sodium, potassium, and phosphorus levels no worse than grade 
Because of the potential risk of corrected QT (QTc) changes, serum potassium levels must be within institutional normal limits
Magnesium within . to . * institutional normal limits, Sodium greater than or equal to  milli equivalent per liter, Potassium within institutional normal limits (within  days prior to Day  of Cycle  up until pre-dose of Cycle )
Potassium within normal limits for the institution
Serum potassium must be within institutional normal limits
Renal function: Serum creatinine ? . x ULN or -hour clearance ?  ml/min, Serum potassium, magnesium and calcium must be within normal limits
Normal serum potassium (K+), magnesium (Mg+), phosphates (PO), and total Ca++ (calcium) (pre-treatment abnormal values may be therapeutically corrected before starting therapy and must be documented as normal or if abnormal values persist must be documented as clinically insignificant)
Serum calcium, magnesium and potassium must be within normal limits; supplementation to achieve normal values is permitted
Potassium with institutional limits (supplementation allowed)
Potassium >= . mg/dL
Potassium within normal limits
Sodium, potassium, chloride, bicarbonate: all =< upper limit of institutional normal
Potassium (K) within  x ULN
Serum potassium, calcium, magnesium, phosphorus within normal limits (may be supplemented)
The patient has serum electrolytes (including calcium, magnesium, phosphorous, sodium and potassium) within normal limits (supplementation to maintain normal electrolytes is allowed).
